Bis[[[[(sulfanylidene-λ4-sulfanylidene)-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfane;4-(4-chloro-6-methoxy-2-methyl-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethyl-1,2-oxazole;4-[6-methoxy-2-methyl-4-[[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]methyl]-9H-pyrimido[4,5-b]indol-7-yl]-3,5-dimethyl-1,2-oxazole;1-methyl-3-(trifluoromethyl)pyrazol-4-amine
C45H42ClF6N13O4S13 — CID 157475018
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis[[[[(sulfanylidene-λ4-sulfanylidene)-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfane;4-(4-chloro-6-methoxy-2-methyl-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethyl-1,2-oxazole;4-[6-methoxy-2-methyl-4-[[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]methyl]-9H-pyrimido[4,5-b]indol-7-yl]-3,5-dimethyl-1,2-oxazole;1-methyl-3-(trifluoromethyl)pyrazol-4-amine
Bis[[[[(sulfanylidene-λ4-sulfanylidene)-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfane;4-(4-chloro-6-methoxy-2-methyl-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethyl-1,2-oxazole;4-[6-methoxy-2-methyl-4-[[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]methyl]-9H-pyrimido[4,5-b]indol-7-yl]-3,5-dimethyl-1,2-oxazole;1-methyl-3-(trifluoromethyl)pyrazol-4-amine (PubChem CID 157475018) has the molecular formula C45H42ClF6N13O4S13 and a molecular weight of 1395.23 g/mol. Its IUPAC name is bis[[[[(sulfanylidene-λ4-sulfanylidene)-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfane;4-(4-chloro-6-methoxy-2-methyl-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethyl-1,2-oxazole;4-[6-methoxy-2-methyl-4-[[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]methyl]-9H-pyrimido[4,5-b]indol-7-yl]-3,5-dimethyl-1,2-oxazole;1-methyl-3-(trifluoromethyl)pyrazol-4-amine.
Molecular Properties
| Compound Name | Bis[[[[(sulfanylidene-λ4-sulfanylidene)-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfane;4-(4-chloro-6-methoxy-2-methyl-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethyl-1,2-oxazole;4-[6-methoxy-2-methyl-4-[[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]methyl]-9H-pyrimido[4,5-b]indol-7-yl]-3,5-dimethyl-1,2-oxazole;1-methyl-3-(trifluoromethyl)pyrazol-4-amine |
|---|---|
| PubChem CID | 157475018 |
| Molecular Formula | C45H42ClF6N13O4S13 |
| Molecular Weight | 1395.23 g/mol |
| Exact Mass | 1392.94 |
| IUPAC Name | bis[[[[(sulfanylidene-λ4-sulfanylidene)-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfanylidene]-λ4-sulfane;4-(4-chloro-6-methoxy-2-methyl-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethyl-1,2-oxazole;4-[6-methoxy-2-methyl-4-[[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]methyl]-9H-pyrimido[4,5-b]indol-7-yl]-3,5-dimethyl-1,2-oxazole;1-methyl-3-(trifluoromethyl)pyrazol-4-amine |
| SMILES | COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Cc3cn(C)nc3C(F)(F)F)c12.COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Cl)c12.Cn1cc(N)c(C(F)(F)F)n1.S=S=S=S=S=S=S=S=S=S=S=S=S |
| InChI | InChI=1S/C23H21F3N6O2.C17H15ClN4O2.C5H6F3N3.S13/c1-10-19(11(2)34-31-10)15-7-16-14(8-18(15)33-5)20-17(27-12(3)28-22(20)29-16)6-13-9-32(4)30-21(13)23(24,25)26;1-7-14(8(2)24-22-7)11-5-12-10(6-13(11)23-4)15-16(18)19-9(3)20-17(15)21-12;1-11-2-3(9)4(10-11)5(6,7)8;1-3-5-7-9-11-13-12-10-8-6-4-2/h7-9H,6H2,1-5H3,(H,27,28,29);5-6H,1-4H3,(H,19,20,21);2H,9H2,1H3; |
| InChIKey | BVMHBZIMFGKVFE-UHFFFAOYSA-N |
| XLogP | 10.39 |
| TPSA | 215.32 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 82 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1395.23 |
| LogP ≤ 5 | 10.39 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157475018 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.